Anti-IL-12/23 in Crohn's disease: bench and bedside.

Current drug targets

Volumn 14, Issue 12, 2013, Pages 1379-1384

  Niederreiter, Lukas ^a   Adolph, Timon Erik ^b   Kaser, Arthur ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRIAKINUMAB; INTERLEUKIN 12P40; INTERLEUKIN 23P19; MONOCLONAL ANTIBODY; USTEKINUMAB;

ANIMAL; CLINICAL TRIAL (TOPIC); CROHN DISEASE; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CLINICAL TRIALS AS TOPIC; CROHN DISEASE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23 SUBUNIT P19;

EID: 84901384833     PISSN: None     EISSN: 18735592     Source Type: Journal    
DOI: None     Document Type: Review

References (0)